CA2902234A1 - Dispositifs, systemes et procedes associes a des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte - Google Patents

Dispositifs, systemes et procedes associes a des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte Download PDF

Info

Publication number
CA2902234A1
CA2902234A1 CA2902234A CA2902234A CA2902234A1 CA 2902234 A1 CA2902234 A1 CA 2902234A1 CA 2902234 A CA2902234 A CA 2902234A CA 2902234 A CA2902234 A CA 2902234A CA 2902234 A1 CA2902234 A1 CA 2902234A1
Authority
CA
Canada
Prior art keywords
screen
sensor
user
glucose
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2902234A
Other languages
English (en)
Inventor
Marc Barry Taub
Jai Karan
Annie C. Tan
Timothy Christian Dunn
Joel Goldsmith
Christine M. Neuhaus
Stephen A. Rossi
Sujit R. Jangam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of CA2902234A1 publication Critical patent/CA2902234A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G06Q10/109—Time management, e.g. calendars, reminders, meetings or time accounting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6879—Means for maintaining contact with the body
    • A61B5/688—Means for maintaining contact with the body using adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/7435—Displaying user selection data, e.g. icons in a graphical user interface

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Human Resources & Organizations (AREA)
  • Strategic Management (AREA)
  • General Business, Economics & Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Quality & Reliability (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marketing (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Economics (AREA)
  • Operations Research (AREA)
  • Theoretical Computer Science (AREA)
  • Tourism & Hospitality (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

L'invention concerne des dispositifs et des systèmes de surveillance d'analyte, et des procédés associés aux dispositifs de surveillance d'analyte, et des dispositifs comprenant lesdits dispositifs de surveillance d'analyte. Des interfaces utilisateurs graphiques (GUI) variées et des flux de navigation sont utilisés pour exécuter des caractéristiques, des activités, des fonctions, etc. variées, associées au dispositif ou au système de surveillance d'analyte. On utilise une navigation intuitive pour améliorer l'interprétation des mesures d'analyte.
CA2902234A 2013-03-15 2014-03-14 Dispositifs, systemes et procedes associes a des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte Abandoned CA2902234A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361801518P 2013-03-15 2013-03-15
US61/801,518 2013-03-15
PCT/US2014/029698 WO2014145049A2 (fr) 2013-03-15 2014-03-14 Dispositifs, systèmes et procédés associés à des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte

Publications (1)

Publication Number Publication Date
CA2902234A1 true CA2902234A1 (fr) 2014-09-18

Family

ID=51538408

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2902234A Abandoned CA2902234A1 (fr) 2013-03-15 2014-03-14 Dispositifs, systemes et procedes associes a des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte

Country Status (6)

Country Link
EP (1) EP2967344A4 (fr)
JP (1) JP6417561B2 (fr)
CN (1) CN105377118B (fr)
AU (1) AU2014233435A1 (fr)
CA (1) CA2902234A1 (fr)
WO (1) WO2014145049A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
WO2014152717A2 (fr) 2013-03-14 2014-09-25 Sano Intelligence, Inc. Microcapteur porté sur le corps destiné à une biosurveillance
US10820860B2 (en) 2013-03-14 2020-11-03 One Drop Biosensor Technologies, Llc On-body microsensor for biomonitoring
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
WO2015138989A1 (fr) 2014-03-13 2015-09-17 Sano Intelligence, Inc. Système de surveillance de chimie du corps
US10595754B2 (en) 2014-03-13 2020-03-24 Sano Intelligence, Inc. System for monitoring body chemistry
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
WO2016069475A1 (fr) 2014-10-27 2016-05-06 Aseko, Inc. Gestion sous-cutanée de patient externe
AR102615A1 (es) * 2014-11-14 2017-03-15 Bayer Healthcare Llc Analizador de analitos
WO2017007775A2 (fr) * 2015-07-06 2017-01-12 Abbott Diabetes Care Inc. Systèmes, dispositifs et procédés de détection et d'évaluation d'épisodes
CN107920955B (zh) * 2015-07-29 2021-06-11 株式会社汤山制作所 混合注射辅助系统
US9886556B2 (en) 2015-08-20 2018-02-06 Aseko, Inc. Diabetes management therapy advisor
KR101889926B1 (ko) * 2016-05-25 2018-08-21 대요메디(주) 혈압측정장치 및 이를 이용한 혈압측정방법
ES2957551T3 (es) * 2016-10-21 2024-01-22 Hoffmann La Roche Procedimiento para resaltar valores de analitos durante una ventana terapéutica
USD824034S1 (en) 2016-12-15 2018-07-24 Sano Intelligence, Inc. Biomonitoring interface device
USD820988S1 (en) 2017-01-20 2018-06-19 Sano Intelligence, Inc. Biomonitoring sensor system for monitoring body chemistry
WO2018153648A1 (fr) * 2017-02-23 2018-08-30 Novo Nordisk A/S Systèmes et procédés permettant de communiquer une dose
US20180256103A1 (en) * 2017-03-08 2018-09-13 Abbott Diabetes Care Inc. Systems, devices, and methods for wellness and nutrition monitoring and management using analyte data
US20180286507A1 (en) * 2017-03-28 2018-10-04 Ascensia Diabetes Care Holdings Ag Diabetes management systems, methods and apparatus for user reminders, pattern recognition, and interfaces
CN110741438B (zh) * 2017-06-15 2023-12-29 诺和诺德股份有限公司 具有适应性靶葡萄糖水平的基础滴定
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
WO2019118532A1 (fr) 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Systèmes, dispositifs et méthodes d'injection de médicament et de gestion de la maladie
ES2866980T3 (es) * 2017-12-12 2021-10-20 Hoffmann La Roche Procedimiento para operar un sistema de suministro de fármaco y sistema de suministro de fármaco
CA3089729A1 (fr) * 2018-02-05 2019-08-08 Abbott Diabetes Care Inc. Notes et informations de journal d'evenements associees a des capteurs d'analyte
US20200405230A1 (en) 2018-03-15 2020-12-31 Coloplast A/S Methods for managing remaining wear time of a medical appliance and related accessory devices
US20200336407A1 (en) * 2019-04-18 2020-10-22 Abbott Diabetes Care Inc. Systems, devices, and methods for handling wireless communications in an analyte monitoring environment
CA3155575A1 (fr) * 2019-09-25 2021-04-01 Janssen Pharmaceuticals, Inc. Dispositifs d'administration de medicament en communication avec des systemes externes et/ou d'autres dispositifs
EP4094264A1 (fr) * 2020-01-23 2022-11-30 Insulet Corporation Détermination de l'insuline du repas pour une meilleure réponse post-prandiale
CA3072883A1 (fr) * 2020-02-13 2021-08-13 Mmhg Inc. Systeme et methode de mesure et de suivi de la pression sanguine et de la glycemie
EP4213727A1 (fr) * 2020-09-17 2023-07-26 Abbott Diabetes Care Inc. Interfaces numériques et interfaces utilisateur pour systèmes de surveillance d'analytes
WO2022085206A1 (fr) * 2020-10-24 2022-04-28 エレファンテック株式会社 Cellule à circulation
WO2022091424A1 (fr) * 2020-11-02 2022-05-05 エレファンテック株式会社 Plaque à puits
USD988882S1 (en) 2021-04-21 2023-06-13 Informed Data Systems Inc. Sensor assembly
AU2022316124A1 (en) * 2021-07-21 2024-01-18 Abbott Diabetes Care Inc. Over-the-air programming of sensing devices

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121170A (en) 1965-12-31 1968-07-24 Ft Products Ltd An improved clip
DE3278334D1 (en) 1981-10-23 1988-05-19 Genetics Int Inc Sensor for components of a liquid mixture
US5509410A (en) 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
US5682884A (en) 1983-05-05 1997-11-04 Medisense, Inc. Strip electrode with screen printing
CA1219040A (fr) 1983-05-05 1987-03-10 Elliot V. Plotkin Mesure de reactions catalysees par des enzymes
SE463604B (sv) 1989-04-25 1990-12-17 Flaekt Ab Anordning foer rening av med faergpartiklar foerorenad ventilationsluft fraan en sprutbox foer maalning
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
CA2050057A1 (fr) 1991-03-04 1992-09-05 Adam Heller Biocapteurs d'elimination d'impuretes
US5899855A (en) 1992-11-17 1999-05-04 Health Hero Network, Inc. Modular microprocessor-based health monitoring system
US5601435A (en) 1994-11-04 1997-02-11 Intercare Method and apparatus for interactively monitoring a physiological condition and for interactively providing health related information
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5918603A (en) 1994-05-23 1999-07-06 Health Hero Network, Inc. Method for treating medical conditions using a microprocessor-based video game
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
US5628890A (en) 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
ATE227844T1 (de) 1997-02-06 2002-11-15 Therasense Inc Kleinvolumiger sensor zur in-vitro bestimmung
US6270455B1 (en) 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
JP2002511965A (ja) * 1997-07-14 2002-04-16 アボツト・ラボラトリーズ 遠隔医療
US6764581B1 (en) 1997-09-05 2004-07-20 Abbott Laboratories Electrode with thin working layer
US6071391A (en) 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
GB2337122B (en) 1998-05-08 2002-11-13 Medisense Inc Test strip
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
WO2000033072A2 (fr) 1998-11-30 2000-06-08 Abbott Laboratories Instrument de mesure d'analyte a procedes d'etalonnage et de communication ameliores
US6161095A (en) 1998-12-16 2000-12-12 Health Hero Network, Inc. Treatment regimen compliance and efficacy with feedback
GB2351153B (en) 1999-06-18 2003-03-26 Abbott Lab Electrochemical sensor for analysis of liquid samples
US6514460B1 (en) 1999-07-28 2003-02-04 Abbott Laboratories Luminous glucose monitoring device
US20060091006A1 (en) 1999-11-04 2006-05-04 Yi Wang Analyte sensor with insertion monitor, and methods
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
WO2001088524A1 (fr) 2000-05-12 2001-11-22 Therasense, Inc. Electrodes a membranes multicouche et procedes d'utilisation et de fabrication de ces electrodes
JP2002159327A (ja) 2000-11-27 2002-06-04 Matsushita Electric Works Ltd 脱毛装置
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1397068A2 (fr) 2001-04-02 2004-03-17 Therasense, Inc. Dispositif et procede de recherche de glucose dans le sang
US6676816B2 (en) 2001-05-11 2004-01-13 Therasense, Inc. Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
EP1578262A4 (fr) 2002-12-31 2007-12-05 Therasense Inc Systeme de controle du glucose en continu, et procedes d'utilisation correspondants
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US20060010098A1 (en) 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system
KR100638727B1 (ko) 2005-02-28 2006-10-30 삼성전기주식회사 Ｚｉｇｂｅｅ 및 불루투스 겸용 송수신기
WO2006133435A2 (fr) * 2005-06-08 2006-12-14 Agamatrix, Inc Systeme de collecte de donnees et interface
US7846311B2 (en) 2005-09-27 2010-12-07 Abbott Diabetes Care Inc. In vitro analyte sensor and methods of use
US20070095661A1 (en) 2005-10-31 2007-05-03 Yi Wang Method of making, and, analyte sensor
US7918975B2 (en) 2005-11-17 2011-04-05 Abbott Diabetes Care Inc. Analytical sensors for biological fluid
US7811430B2 (en) 2006-02-28 2010-10-12 Abbott Diabetes Care Inc. Biosensors and methods of making
US7866026B1 (en) 2006-08-01 2011-01-11 Abbott Diabetes Care Inc. Method for making calibration-adjusted sensors
US7822557B2 (en) 2006-10-31 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods
US7802467B2 (en) 2006-12-22 2010-09-28 Abbott Diabetes Care Inc. Analyte sensors and methods of use
CN101610714A (zh) * 2007-02-15 2009-12-23 雅培糖尿病护理公司 用于自动数据获取和/或检测的设备及方法
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
BRPI0810520A2 (pt) 2007-04-27 2014-10-21 Abbott Diabetes Care Inc Identificação de tira de teste utilizando modelos condutivos
US8983568B2 (en) 2008-09-30 2015-03-17 Abbott Diabetes Care Inc. Analyte sensors comprising leveling agents
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
EP2394217A4 (fr) 2009-02-04 2016-05-04 Abbott Diabetes Care Inc Dispositif de test d'analyte multifonction et ses procédés
DK3912551T3 (da) 2009-02-26 2023-10-30 Abbott Diabetes Care Inc Fremgangsmåde til kalibrering af en analytsensor
JP5711156B2 (ja) * 2009-02-27 2015-04-30 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． 薬物送達システム
WO2010141922A1 (fr) 2009-06-04 2010-12-09 Abbott Diabetes Care Inc. Procédé et système de mise à jour d'un dispositif médical
US8000763B2 (en) 2009-06-30 2011-08-16 Abbott Diabetes Care Inc. Integrated devices having extruded electrode structures and methods of using same
EP2456361B1 (fr) 2009-07-23 2019-12-11 Abbott Diabetes Care, Inc. Système de dosage d'analytes en continu
WO2011032177A2 (fr) * 2009-09-14 2011-03-17 Masimo Laboratories, Inc. Système de crédit avec un dispositif de surveillance de vérification ponctuelle
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
WO2011133768A1 (fr) 2010-04-22 2011-10-27 Abbott Diabetes Care Inc. Dispositifs, systèmes et procédés liés à la surveillance et la gestion d'analytes
CN102163206B (zh) * 2011-01-30 2013-05-01 青岛海信传媒网络技术有限公司 页面加载方法及系统
WO2012108938A1 (fr) * 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Applications logicielles résidant sur des dispositifs portatifs de détermination d'analyte
CN103619255B (zh) * 2011-02-28 2016-11-02 雅培糖尿病护理公司 与分析物监测装置关联的装置、系统和方法以及结合了它们的装置

Also Published As

Publication number Publication date
JP2016517601A (ja) 2016-06-16
WO2014145049A2 (fr) 2014-09-18
JP6417561B2 (ja) 2018-11-07
EP2967344A4 (fr) 2016-11-23
CN105377118B (zh) 2019-09-17
EP2967344A2 (fr) 2016-01-20
CN105377118A (zh) 2016-03-02
WO2014145049A3 (fr) 2014-12-04
AU2014233435A1 (en) 2015-09-03

Similar Documents

Publication Publication Date Title
US20220110551A1 (en) Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
AU2021215294B2 (en) Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
CA2902234A1 (fr) Dispositifs, systemes et procedes associes a des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte
US9339219B2 (en) Devices, systems, and methods related to analyte monitoring and management
US20240000348A1 (en) Multi-function analyte monitor device and methods of use
US20110256024A1 (en) Modular Analyte Monitoring Device
EP3568863A1 (fr) Systèmes, dispositifs et procédés de détection et d'évaluation d'épisode avec des guides de visite et des plans d'action
AU2022261912A1 (en) Systems and methods for diabetes management

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190312

FZDE Discontinued

Effective date: 20210831